Patent Assignment
Reel/Frame 060096/0689
CHANGE OF NAME
Recorded: 2022-06-03
Received: 2022-06-03
Pages: 11
Assignor
SUMITOMO DAINIPPON PHARMA CO., LTD.
Executed: 2022-04-01
Assignee
SUMITOMO PHARMA CO., LTD.
6-8, DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, JPX, 541-0045, JAPAN
Covered Applications
(10)
ALIPHATIC ACID AMIDE DERIVATIVE
App. No. 17/528,743
→
ALIPHATIC ACID AMIDE DERIVATIVE
App. No. 17/612,099
→
BLEND COMPOSITIONS FOR ORAL ADMINISTRATION AS A RAPIDLY DISSOLVING POWDER AND/OR SUSPENSION
App. No. 17/245,414
→
MEDICINAL PREPARATION FOR EXTERNAL USE
App. No. 17/260,123
→
SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINES AS NEGATIVE ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTOR
App. No. 16/764,962
→
SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY
App. No. 16/637,335
→
2,6-DISUBSTITUTED PYRIDINE DERIVATIVE
App. No. 16/487,936
→
THERAPEUTIC AGENT FOR NON-MOTOR SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE
App. No. 16/476,925
→
LIGHT CONVERTING DEVICE WITH CONFINED LIGHT CONVERTER
App. No. 16/276,984
→
PYRAZOLE COMPOUND
App. No. 14/324,509
→